Application of lamivudine and domperidone in combination for the preparation of sedative drugs
A technology of domperidone and lamivudine, applied in the application of domperidone combined for the preparation of sedative drugs, in the field of lamivudine, can solve the problems such as no sedative effect or central nervous system inhibition effect of lamivudine or domperidone
Active Publication Date: 2021-04-30
ZHANG ZHOU HALTH VOCATIONAL COLLEGE
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
In the prior art, no lamivudine or domperidone has been found to have a sedative effect or a central nervous system inhibitory effect on the human body
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] A sedative drug consisting of lamivudine and domperidone, wherein the dose of lamivudine is 19.08 mg / d, and the dose of domperidone is 6 mg / d.
Embodiment 2
[0031] A sedative drug consisting of lamivudine and domperidone, wherein the dose of lamivudine is 20.08 mg / d, and the dose of domperidone is 5 mg / d.
Embodiment 3
[0033] A sedative drug consisting of lamivudine and domperidone, wherein the dose of lamivudine is 18.08 mg / d, and the dose of domperidone is 7 mg / d.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention provides the application of combining lamivudine and domperidone to prepare sedative medicine. The research of the present invention finds that when lamivudine and domperidone are used in combination in a specific ratio, they can have a definite sedative effect; moreover, the sedative effect is relatively mild and will not cause loss of communication ability or difficulty in awakening. Further studies on pharmacological properties showed that the drug can promote GABA and GABA A Receptor binding increases the opening frequency of chloride ion channels; at the same time, it down-regulates the content of glutamate in the cerebral cortex and hypothalamus of experimental animals, thereby reducing the excitatory neurotoxicity in the brain; moreover, it can selectively bind to 5-hydroxytryptamine 1A receptors and inhibit Synaptic uptake of serotonin leading to upregulation of serotonin levels. Based on the above novel properties found, the present invention determines the new application of lamivudine and domperidone in combination for the preparation of sedative drugs, which not only expands the optional range of sedative drugs, but also improves the sedative effect to a certain extent.
Description
technical field [0001] The invention relates to the technical field of medicinal chemistry, and further relates to the new medical application of substances, in particular to the application of lamivudine and domperidone in combination for the preparation of sedative drugs. Background technique [0002] Sedatives are a general term for a large class of drugs that promote calmness and sleep in the human body, and are mainly used for symptomatic treatment of symptoms such as anxiety and irritability in mental disorders. Ideal sedative drugs need to have the following characteristics: 1. Little impact on circulation and respiration; 2. Quick onset and obvious effect; 3. Fast drug metabolism and basically no obvious accumulation effect; 4. Little impact on liver and kidney functions 5. Excellent anti-anxiety and adaptive amnesia effects, easy to wake up when using, and quickly restore consciousness after stopping the drug. Currently, commonly used sedatives mainly include benzo...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/513A61K31/728A61P25/20A61K31/454A61K31/455A61K31/7048
CPCA61K31/454A61K31/455A61K31/513A61K31/7048A61K31/728A61P25/20A61K2300/00
Inventor 颜晓萍戴云翔李嫣妮郑文忠
Owner ZHANG ZHOU HALTH VOCATIONAL COLLEGE
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap